Literature DB >> 18178742

CmeR functions as a pleiotropic regulator and is required for optimal colonization of Campylobacter jejuni in vivo.

Baoqing Guo1, Ying Wang, Feng Shi, Yi-Wen Barton, Paul Plummer, Donald L Reynolds, Dan Nettleton, Tara Grinnage-Pulley, Jun Lin, Qijing Zhang.   

Abstract

CmeR functions as a transcriptional repressor modulating the expression of the multidrug efflux pump CmeABC in Campylobacter jejuni. To determine if CmeR also regulates other genes in C. jejuni, we compared the transcriptome of the cmeR mutant with that of the wild-type strain using a DNA microarray. This comparison identified 28 genes that showed a > or = 2-fold change in expression in the cmeR mutant. Independent real-time quantitative reverse transcription-PCR experiments confirmed 27 of the 28 differentially expressed genes. The CmeR-regulated genes encode membrane transporters, proteins involved in C4-dicarboxylate transport and utilization, enzymes for biosynthesis of capsular polysaccharide, and hypothetical proteins with unknown functions. Among the genes whose expression was upregulated in the cmeR mutant, Cj0561c (encoding a putative periplasmic protein) showed the greatest increase in expression. Subsequent experiments demonstrated that this gene is strongly repressed by CmeR. The presence of the known CmeR-binding site, an inverted repeat of TGTAAT, in the promoter region of Cj0561c suggests that CmeR directly inhibits the transcription of Cj0561c. Similar to expression of cmeABC, transcription of Cj0561c is strongly induced by bile compounds, which are normally present in the intestinal tracts of animals. Inactivation of Cj0561c did not affect the susceptibility of C. jejuni to antimicrobial compounds in vitro but reduced the fitness of C. jejuni in chickens. Loss-of-function mutation of cmeR severely reduced the ability of C. jejuni to colonize chickens. Together, these findings indicate that CmeR governs the expression of multiple genes with diverse functions and is required for Campylobacter adaptation in the chicken host.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18178742      PMCID: PMC2258875          DOI: 10.1128/JB.01796-07

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  48 in total

1.  Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation.

Authors:  Yee Hwa Yang; Sandrine Dudoit; Percy Luu; David M Lin; Vivian Peng; John Ngai; Terence P Speed
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

2.  A phase-variable capsule is involved in virulence of Campylobacter jejuni 81-176.

Authors:  D J Bacon; C M Szymanski; D H Burr; R P Silver; R A Alm; P Guerry
Journal:  Mol Microbiol       Date:  2001-05       Impact factor: 3.501

Review 3.  C4-dicarboxylate carriers and sensors in bacteria.

Authors:  I G Janausch; E Zientz; Q H Tran; A Kröger; G Unden
Journal:  Biochim Biophys Acta       Date:  2002-01-17

4.  The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences.

Authors:  J Parkhill; B W Wren; K Mungall; J M Ketley; C Churcher; D Basham; T Chillingworth; R M Davies; T Feltwell; S Holroyd; K Jagels; A V Karlyshev; S Moule; M J Pallen; C W Penn; M A Quail; M A Rajandream; K M Rutherford; A H van Vliet; S Whitehead; B G Barrell
Journal:  Nature       Date:  2000-02-10       Impact factor: 49.962

5.  Demonstration of polysaccharide capsule in Campylobacter jejuni using electron microscopy.

Authors:  A V Karlyshev; M V McCrossan; B W Wren
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

6.  The Campylobacter jejuni PhosS/PhosR operon represents a non-classical phosphate-sensitive two-component system.

Authors:  Marc M S M Wösten; Craig T Parker; Andries van Mourik; Magalie R Guilhabert; Linda van Dijk; Jos P M van Putten
Journal:  Mol Microbiol       Date:  2006-08-31       Impact factor: 3.501

7.  RpoD promoters in Campylobacter jejuni exhibit a strong periodic signal instead of a -35 box.

Authors:  Lise Petersen; Thomas S Larsen; David W Ussery; Stephen L W On; Anders Krogh
Journal:  J Mol Biol       Date:  2003-03-07       Impact factor: 5.469

8.  Growth of Campylobacter jejuni supported by respiration of fumarate, nitrate, nitrite, trimethylamine-N-oxide, or dimethyl sulfoxide requires oxygen.

Authors:  Michael J Sellars; Stephen J Hall; David J Kelly
Journal:  J Bacteriol       Date:  2002-08       Impact factor: 3.490

9.  The structures of the lipooligosaccharide and capsule polysaccharide of Campylobacter jejuni genome sequenced strain NCTC 11168.

Authors:  Frank St Michael; Christine M Szymanski; Jianjun Li; Kenneth H Chan; Nam Huan Khieu; Suzon Larocque; Warren W Wakarchuk; Jean-Robert Brisson; Mario A Monteiro
Journal:  Eur J Biochem       Date:  2002-11

10.  CmeABC functions as a multidrug efflux system in Campylobacter jejuni.

Authors:  Jun Lin; Linda Overbye Michel; Qijing Zhang
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

View more
  34 in total

1.  Critical role of LuxS in the virulence of Campylobacter jejuni in a guinea pig model of abortion.

Authors:  Paul Plummer; Orhan Sahin; Eric Burrough; Rachel Sippy; Kathy Mou; Jessica Rabenold; Mike Yaeger; Qijing Zhang
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

2.  Quality control strain Campylobacter jejuni ATCC 33560 contains a frameshift mutation in the CmeR regulator.

Authors:  Heidi Hyytiäinen; Marja-Liisa Hänninen
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

3.  Prevalence, development, and molecular mechanisms of bacteriocin resistance in Campylobacter.

Authors:  Ky Van Hoang; Norman J Stern; Arnold M Saxton; Fuzhou Xu; Ximin Zeng; Jun Lin
Journal:  Appl Environ Microbiol       Date:  2011-01-28       Impact factor: 4.792

4.  Transcriptome analysis of Campylobacter jejuni polyphosphate kinase (ppk1 and ppk2) mutants.

Authors:  Kshipra Chandrashekhar; Issmat I Kassem; Corey Nislow; Dharanesh Gangaiah; Rosario A Candelero-Rueda; Gireesh Rajashekara
Journal:  Virulence       Date:  2015-11-05       Impact factor: 5.882

5.  Impaired fitness and transmission of macrolide-resistant Campylobacter jejuni in its natural host.

Authors:  Taradon Luangtongkum; Zhangqi Shen; Virginia W Seng; Orhan Sahin; Byeonghwa Jeon; Peng Liu; Qijing Zhang
Journal:  Antimicrob Agents Chemother       Date:  2011-12-19       Impact factor: 5.191

6.  Mutational and transcriptomic changes involved in the development of macrolide resistance in Campylobacter jejuni.

Authors:  Haihong Hao; Zonghui Yuan; Zhangqi Shen; Jing Han; Orhan Sahin; Peng Liu; Qijing Zhang
Journal:  Antimicrob Agents Chemother       Date:  2012-12-28       Impact factor: 5.191

7.  Salicylate functions as an efflux pump inducer and promotes the emergence of fluoroquinolone-resistant Campylobacter jejuni mutants.

Authors:  Zhangqi Shen; Xiao-Ying Pu; Qijing Zhang
Journal:  Appl Environ Microbiol       Date:  2011-08-05       Impact factor: 4.792

8.  Correlation between gyrA and CmeR Box Polymorphism and Fluoroquinolone Resistance in Campylobacter jejuni Isolates in China.

Authors:  Tengfei Zhang; Yiluo Cheng; Qingping Luo; Qin Lu; Jun Dong; Rongrong Zhang; Guoyuan Wen; Honglin Wang; Ling Luo; Hongcai Wang; Guoping Liu; Huabin Shao
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

9.  Hyperosmotic stress response of Campylobacter jejuni.

Authors:  Andrew Cameron; Emilisa Frirdich; Steven Huynh; Craig T Parker; Erin C Gaynor
Journal:  J Bacteriol       Date:  2012-09-07       Impact factor: 3.490

10.  Outcome of infection of C57BL/6 IL-10(-/-) mice with Campylobacter jejuni strains is correlated with genome content of open reading frames up- and down-regulated in vivo.

Authors:  J A Bell; J P Jerome; A E Plovanich-Jones; E J Smith; J R Gettings; H Y Kim; J R Landgraf; T Lefébure; J J Kopper; V A Rathinam; J L St Charles; B A Buffa; A P Brooks; S A Poe; K A Eaton; M J Stanhope; L S Mansfield
Journal:  Microb Pathog       Date:  2012-08-31       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.